Histone Demethylase Jumonji D3 (JMJD3) as a Tumor Suppressor by Regulating p53 Protein Nuclear Stabilization

• Chibawanye I. Ene,

  Affiliations Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America, NIH-Oxford-Cambridge Research Scholars Program, National Institute of Health (NIH), Bethesda, Maryland, United States of America

  ⨯
• Lincoln Edwards,

  Affiliation Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Gregory Riddick,

  Affiliation Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Mehmet Baysan,

  Affiliation Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Kevin Woolard,

  Affiliation Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Svetlana Kotliarova,

  Affiliation Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Chen Lai,

  Affiliation Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Galina Belova,

  Affiliation Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Maggie Cam,

  Affiliation Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Jennifer Walling,

  Affiliation Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Ming Zhou,

  Affiliation Laboratory of Proteomics and Analytical Technologies, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institute of Health (NIH), Frederick, Maryland, United States of America

  ⨯
• Holly Stevenson,

  Affiliation Molecular Profiling Core, Genetics Branch, National Cancer Institute, National Institute of Health (NIH), Bethesda, Maryland, United States of America

  ⨯
• Hong Sug Kim,

  Affiliation Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Keith Killian,

  Affiliation Molecular Profiling Core, Genetics Branch, National Cancer Institute, National Institute of Health (NIH), Bethesda, Maryland, United States of America

  ⨯
• Timothy Veenstra,

  Affiliation Laboratory of Proteomics and Analytical Technologies, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institute of Health (NIH), Frederick, Maryland, United States of America

  ⨯
• Rolanda Bailey,

  Affiliation Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Hua Song,

  Affiliation Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Wei Zhang,

  Affiliation Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
•  [ ... ],
• Howard A. Fine

  * E-mail: Howard.Fine@nyumc.org

  Affiliation New York University Cancer Center, New York University, Langone Medical Center, New York, New York, United States of America

  ⨯
• [ view all ]
• [ view less ]